Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TIPRANAVIR vs TIRZEPATIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TIPRANAVIR vs TIRZEPATIDE: Safety Overview

Metric TIPRANAVIR TIRZEPATIDE
Total FAERS Reports 403 99,893
Deaths Reported 14 455
Death Rate 3.5% 0.5%
Hospitalizations 261 5,527
Average Patient Age 48.2 yrs 53.9 yrs
% Female Patients 82.9% 75.6%
FDA Approval Date Jun 22, 2005 Jan 20, 2026
Manufacturer Boehringer Ingelheim Pharmaceuticals,... Eli Lilly and Company
Route ORAL N/A
Marketing Status Prescription Prescription